Widthness LLC

Advanced Business and Technology – Intel® Xeon® and A.I. Powered

Eli Lilly is eyeing an off-ramp for patients to switch from weight loss injections to pills

1 min read
Eli Lilly is eyeing an off-ramp for patients to switch from weight loss injections to pills

Photo credit: Karola G via Pexels. Article by Catherine Arnst. Quartz – December 18, 2025.

Although the injectable forms of the popular GLP-1 drugs are more effective, the pills under development are both easier to take and will be cheaper

Eli Lilly reported on Thursday that orforglipron, its experimental pill for obesity, helped a majority of patients in a clinical trial maintain their weight loss after switching from injectable forms of its Zepbound GLP-1 drug and Novo Nordisk’s Wegovy. […]

Click here to view original web page at www.qz.com

The owner of this website has made a commitment to accessibility and inclusion, please report any problems that you encounter using the contact form on this website. This site uses the WP ADA Compliance Check plugin to enhance accessibility.